Hydra Biosciences, backed by MedImmune, Eli Lilly and Biogen Idec, raised the cash as it inked a deal with Boehringer Ingelheim to help develop its technology.

Ontario Capital Growth Corporation gains $19m as Affinium Pharmaceuticals is acquired by Swiss biopharmaceutical Debiopharm International.

Johnson & Johnson-backed Galapagos, already listed in Amsterdam and Brussels, has filed for an initial public offering in the US.

The biopharmaceutical company, the developer of a treatment for atrial fibrillation, raised the cash from investors including industrial corporate SMS.

Lundbeck-backed injectable bone graft developer Bonesupport has attracted $14m for a funding round led by an unnamed Scandinavian pension fund.

Chongqinq Lummy Pharmaceutical has backed a $50m fund formed by venture capital firm TVM to invest in life sciences companies.

IBM has agreed to acquire healthcare IT services provider Explorys for an undisclosed sum, enabling Cleveland Clinic to exit.

Novartis and Eli Lilly both took part in a series D round that will fund clinical trials for Innocrin's breast cancer treatments.